3 Study Modules
- Focused learning providing background and clinical context for each live session.
Endorsed by
In Educational collaboration with
Practical, expert-led learning across MASLD/MASH, chronic liver disease and cardiometabolic care.
About the Course
A practical, expert-led course designed to help physicians navigate MASLD/MASH, chronic liver disease and cardiometabolic risk through focused study modules, live sessions and case-based discussions.
The course brings together leading international experts to provide practical, evidence-based approaches to early recognition, clinical evaluation, risk stratification and integrated management.
Program Format
An expert-led educational course providing practical, evidence-based approaches to metabolic liver disease, clinical evaluation, noninvasive assessment, fibrosis risk stratification and integrated cardiometabolic care.
Faculty
Austria
Head, Division of Gastroenterology and Hepatology, Medical University of Vienna
USA
Chief, Division of Endocrinology, Diabetes & Metabolism, University of Florida
USA
Professor of Medicine, Division of Gastroenterology, Virginia Commonwealth University
USA
Medical Director, AdventHealth Diabetes Institute, Florida
USA
Transplant hepatologist, Mayo Clinic, Minnesota
UK
Professor of Cardiometabolic Medicine, University of Glasgow, Scotland
Curriculum Overview
Supported by expert-curated study modules
Module 1Live Session 15ᵗʰ September, 20268 PM IST | 10:30 AM EDT
Prof. Michael Trauner
Approach to Metabolic Liver Disease (MASLD/MASH): Early Recognition, Diagnosis and Clinical Evaluation
Prof. Kenneth Cusi
Metabolic Liver Disease (MASLD/MASH) in Clinical Practice: Screening, Risk Stratification and the Role of Biomarkers
Module 2Live Session 23ʳᵈ October, 20268 PM IST | 10:30 AM EDT
Prof. Arun Sanyal
MASLD/MASH and Common Chronic Liver Diseases: Diagnosis, Risk Stratification & Contemporary Management
Dr. Richard Pratley
Metabolic Dysfunction (MASLD/MASH) and Chronic Liver Disease: An Integrated Clinical Approach
Module 3Live Session 319ᵗʰ December, 20268 PM IST | 09:30 AM EST
Dr. Patrick Kamath
Case-based Approach to Alcohol-Associated Liver Disease, MetALD and Metabolic Liver Disease
Prof. Naveed Sattar
Integrating Liver Care with Cardiometabolic Risk Management – A Practical Framework
Learning Objectives
By the end of this course, participants will be able to
Identify and clinically evaluate MASLD/MASH earlier in people with diabetes, prediabetes, obesity and cardiovascular risk factors.
Apply biomarkers, noninvasive screening and fibrosis risk-stratification tools.
Recognise and manage common chronic liver diseases and coexisting etiologies.
Understand the relationship between MASLD/MASH and cardiometabolic disease.
Evaluate alcohol-associated liver disease and MetALD.
Integrate liver health, diabetes care, weight management and cardiovascular risk reduction.
Certificate
Complete the study modules, attend the live sessions and successfully complete the assessment to earn the American Association for the Study of Liver Diseases (AASLD) & the American Diabetes Association (ADA) joint Certificate of Completion.
The programme is endorsed by the American Association for the Study of Liver Diseases (AASLD) and developed in educational collaboration with the American Diabetes Association (ADA).
AASLD's endorsement applies to the overall educational programme. ADA's educational collaboration focuses on programme content related to MASLD/MASH, diabetes and cardiometabolic risk.
Continue Your Learning
Join leading international experts for a practical learning journey focused on metabolic liver disease and hepato-metabolic care.
Scientific Initiative by
Supported by
From the Makers of
